Alyeska Investment Group
CYNA

Alyeska Investment Group’s CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) CYNA Stock Holding History

Alyeska Investment Group’s Portfolio CYNA Stock Details CYNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-15,000
Closed -$244K – 581
2015
Q2 		$244K Buy
+15,000
New +$246K ﹤0.01% 474

Other funds holding CYNA

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Alyeska Investment Group's CYNA Position: Q3 2015 in Review

Alyeska Investment Group sold out of CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) (CYNA) in Q3 2015, closing a stake of 15,000 shares — an estimated $244K sold.

Alyeska Investment Group first reported a position in CYNA in Q2 2015 and held it in 1 quarter. The position peaked at $244K in Q2 2015. 28 funds tracked by Wall St. Rank hold CYNA as of Q3 2015.

  • Alyeska Investment Group reported no remaining CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position as of Q3 2015 after selling out during the quarter.
  • Alyeska Investment Group sold 15,000 CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) shares in Q3 2015, an estimated $244K.
  • Alyeska Investment Group first reported a position in CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) in Q2 2015 and held it in 1 quarter.
  • Alyeska Investment Group's CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position peaked at $244K in Q2 2015.
  • 28 funds tracked by Wall St. Rank held CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) as of Q3 2015.

Based on Alyeska Investment Group's 13F filing for Q3 2015, filed 16 Nov 2015.